{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:51:08Z","timestamp":1792461068348,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":684,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018465","name":"Regado Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006221","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jcin.2011.06.012","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T00:15:37Z","timestamp":1316477737000},"page":"1011-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"4","author":[{"given":"Adam J.","family":"Saltzman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimmer E.","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene","family":"Leon-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giora","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Witzenbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Guagliumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Kornowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Christopher","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J.","family":"Lansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Nikolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.","family":"Dangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2011.06.012_bib1","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.06.012_bib2","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.CIR.0000016359.94919.16","volume":"105","author":"Januzzi","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.06.012_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ahj.2004.12.002","article-title":"The relation of renal function to ischemic and bleeding outcomes with 2 different glycoprotein IIb\/IIIa inhibitors: the Do Tirofiban and ReoPro Give Similar Efficacy Outcome (TARGET) trial","volume":"149","author":"Berger","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2011.06.012_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjcard.2004.08.089","article-title":"Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents","volume":"95","author":"Lemos","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2011.06.012_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2005.03.018","article-title":"Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention","volume":"151","author":"Blackman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2011.06.012_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.105.591990","article-title":"Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up","volume":"113","author":"Hillis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.06.012_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2005.08.057","article-title":"Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes","volume":"119","author":"Han","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jcin.2011.06.012_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9149(03)00970-6","article-title":"Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials","volume":"92","author":"Chew","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2011.06.012_bib9","first-page":"701","article-title":"The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction","volume":"70","author":"Vasu","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2011.06.012_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcin.2008.06.012","article-title":"In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry","volume":"2","author":"Latif","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2011.06.012_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2011.06.012_bib12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archinternmed.2010.95","article-title":"Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project","volume":"170","author":"Goldenberg","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcin.2011.06.012_bib13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jcin.2009.05.018","volume":"2","author":"Mehran","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2011.06.012_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00129784-200505050-00002","article-title":"Anticoagulant use in patients with chronic renal impairment","volume":"5","author":"Grand'Maison","year":"2005","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jcin.2011.06.012_bib15","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2004.06.072","article-title":"The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease","volume":"44","author":"Ezekowitz","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2011.06.012_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjcard.2004.11.003","article-title":"Bivalirudin versus heparin and glycoprotein IIb\/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)","volume":"95","author":"Chew","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2011.06.012_bib17","doi-asserted-by":"crossref","first-page":"105S","DOI":"10.1592\/phco.22.10.105S.33616","article-title":"Clinical pharmacology of bivalirudin","volume":"22","author":"Reed","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcin.2011.06.012_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/BF02827247","article-title":"Increased thrombin generation in patients with chronic renal failure","volume":"27","author":"Sagripanti","year":"1997","journal-title":"Int J Clin Lab Res"},{"key":"10.1016\/j.jcin.2011.06.012_bib19","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2011.06.012_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(09)61484-7","article-title":"Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial","volume":"374","author":"Mehran","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2011.06.012_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial: study design and rationale","volume":"156","author":"Mehran","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2011.06.012_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.jcin.2011.06.012_bib23","first-page":"5","article-title":"Nutritional anaemias","volume":"405","year":"1968","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.jcin.2011.06.012_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/ki.2009.295","article-title":"The impact of transient and persistent acute kidney injury on long-term outcomes after acute myocardial infarction","volume":"76","author":"Goldberg","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcin.2011.06.012_bib25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/j.ajkd.2009.04.031","article-title":"Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention","volume":"54","author":"Seyfarth","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jcin.2011.06.012_bib26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2011.06.012_bib27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1046\/j.1523-1755.2001.00040.x","article-title":"Coronary artery disease in uremia: etiology, diagnosis, and therapy","volume":"60","author":"Goldsmith","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.jcin.2011.06.012_bib28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000189522","article-title":"Bleeding and thrombosis in chronic uremia","volume":"75","author":"Sagripanti","year":"1997","journal-title":"Nephron"},{"key":"10.1016\/j.jcin.2011.06.012_bib29","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2011.06.012_bib30","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879811005450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879811005450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:57:21Z","timestamp":1761847041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879811005450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1936879811005450"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2011.06.012","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2011.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}